HUM-MOLGEN archive: ANNO: new meetings and positions; Nov 1995

Note from the editor: >From now on the ANNOs and CALLs updates will appear approximately once a month, for your and our convenience. In this ANNO: We have three new meetings, and a lot of new job opportunities both in the academic and commercial field. If you are not interested in a job yourself, please give a print-out to one of your colleagues who might. Please acknowledge HUM-MOLGEN in your application! Good luck and Have a nice day, Arthur Bergen *********************************************************************** New meetings (3) This message was originally submitted by BSmail7373@AOL.COM to the HUM-MOLGEN The Seventh Annual International Conference on Jewish Medical Ethics will take place February 16-19, 1996 at the Radisson Hotel near San Francisco. Among the many topics to be considered will be genetic screening. There will be two plenary lectures on the topic, plus a panel discussion. In addition, there will be a seperate workshop held on the topic of Jewish genetic diseases. The conference is sponsored by the San Francisco-based Institute for Jewish Medical Ethics. Stanford University School of Medicine and the Institute for Behavioral Health Care offer CME and CE credit for the course (up to 24.75 hours). Anyone interested in the conference should include their street address in an e-mail message to: bsmal7373@aol.com. Thank you. Sincerely, Barry L. Smail, Executive Director Institute for Jewish Medical Ethics 1/800-258-4427 1/415-752-7333 FAX 752-5851 645 14th Ave., San Francisco, CA 94118 ___________________________________________________________________________ Subj: ANNO,NEWS: New Developements in Cancer Conference This message was originally submitted by alecs@MAIL.MED.UPENN.EDU to the HUM-MOLGEN list at NIC.SURFNET.NL. NEW DEVELOPMENTS IN CANCER: Focus on Genetics in Clinical Practice A conference sponsored by: University of Pennsylvania Cancer Center Friday, December 15, 1995 The Rittenhouse 210 West Rittenhouse Square Philadelphia, Pennsylvania To register, call (215-349-8387) or e-mail (jas@mail.med.upenn.edu), including the following information: Name, Degree, SS#, Campus Address, Tel #, Specialty, and Institutional Affiliation. For those registrants who are not faculty, staff, fellows or students of the University of Pennsylvania nor members of the University of Pennsylvania Cancer Network, please mail your registration fee separately; $125-Physicians, $60-Nurses and other health care professionals. Checks should be made payable to Trustees, University of Pennsylvania. Send to: University of Pennsylvania Cancer Center, 6 Penn Tower, 3400 Spruce St., Philadelphia, PA 19104. Checks must be received by December 1, 1995. Program Overview The recent identification of genes that confer susceptibility to a number of adult onset cancers has made the dream of predictive testing for cancer risk a reality. These discoveries also hold the promise of greater understanding of the basic mechanisms by which cancers arise. However, these strides present novel challenges to clinicians integrating the discoveries into practice and educating patients about the power and problems inherent in doing so. This program will provide an overview of genetics in relation to clinical practice, as well as updates on the genetics of breast, ovarian, colon and thyroid cancers and melanoma. Additional presentations will provide a framework for utilizing this information in practice, discuss insurance industry views of reimbursement for predictive testing and its relationship to insurability, and give an overview of the ethical issues surrounding predictive testing. This program will be of interest to any health care provider likely to encounter patients with a family history of cancer, including but not limited to medical and surgical oncologists, family practitioners, general surgeons, internists and obstetricians-gynecologists. Nurses, genetic counselors and other providers with similar patient populations are encouraged to attend. Program Objectives At the completion of this conference, participants should be able to: 1. Understand the basic principles of cancer genetics as they relate to clinical practice. 2. Review recent progress in the genetics of specific tumor types. 3. Identify patients who are suitable candidates for susceptibility testing for specific cancers and discuss the counseling needs of these patients. 4. Examine the ethical, legal and social implications of genetic testing for cancer risk. Conference Faculty Chair Barbara L. Weber, MD Director, Breast Cancer Program Associate Professor, Medicine (Hem/Onc) and Genetics University of Pennsylvania Cancer Center Faculty C. Richard Boland, MD Professor of Medicine University of Michigan School of Medicine Kathleen A. Calzone, RN, BSN Nursing Coordinator, Cancer Risk Evaluation Program University of Pennsylvania Cancer Center Arthur L. Caplan, PhD Trustee, Professor of Bioethics Director, Center for Bioethics University of Pennsylvania Medical Center DuPont Guerry, IV, MD Professor, Medicine (Hem/Onc) University of Pennsylvania Cancer Center Jeffrey A. Norton, MD Professor, Surgery Chief, Endocrine and Oncologic Surgery Washington University School of Medicine Kenneth Offit, MD, MPH Chief, Clinical Genetics Service Memorial Sloan-Kettering Cancer Center Jill E. Stopfer, MS, CGC Familial Cancer Coordinator, Cancer Risk Evaluation Program University of Pennsylvania Cancer Center Gary M. Owens, MD Senior Medical Director Independence Blue Cross Accreditation The University of Pennsylvania School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to sponsor continuing medical education for physicians. The University of Pennsylvania School of Medicine designates this continuing medical education activity for 7 credit hours of Category 1 of the Physician's Recognition Award of the American Medical Association. This offering for 6.4 contact hours is provided by the University of Pennsylvania School of Nursing, which is accredited as a provider of continuing education in nursing by the American Nurses Credentialing Centers Commission on Accreditation. Registration and Fees Because space is limited, early registration is advised. The registration deadline is December 1, 1995. Full refunds will be provided for cancellations received by December 1, 1995. The registration fee is $125 for physicians and $60 for nurses and other health care professionals. Registration includes tuition, luncheon and program materials. Fees will be waived for faculty, staff, fellows and students of the University of Pennsylvania and physicians and staff at hospitals in the University of Pennsylvania Cancer Network. -To register, call (215-349-8387) or e-mail (jas@mail.med.upenn.edu), including the following information: Name, Degree, SS#, Campus Address, Tel #, Specialty, and Institutional Affiliation. For those registrants who are not faculty, staff, fellows or students of the University of Pennsylvania nor members of the University of Pennsylvania Cancer Network, please mail your registration fee separately; $125-Physicians, $60-Nurses and other health care professionals. Checks should be made payable to Trustees, University of Pennsylvania. Send to: University of Pennsylvania Cancer Center, 6 Penn Tower, 3400 Spruce St., Philadelphia, PA 19104. Checks must be received by December 1, 1995.- Course Location This program will be held at The Rittenhouse, which is located on the west side of Rittenhouse Square in Center City, Philadelphia. The Rittenhouse is 5 minutes from Amtrak's train station at 30th and Market streets and 20 minutes from the Philadelphia Airport. It is close to major highways, including I-95 and I-76. For directions, call 215-349-8387. Accommodations The Rittenhouse has a limited number of hotel rooms available for attendees of this conference ($175 plus tax for single occupancy). For reservations, please call the Rittenhouse at 215-546-9000, identifying this conference by name. Program Schedule Morning Session Presentations 8:00-8:30 Registration/Continental Breakfast 8:30-8:45 Welcome and Introduction John H. Glick, MD Barbara L. Weber, MD 8:45-9:15 New Perspectives on Cancer as a Hereditary Disease Kenneth Offit, MD, MPH 9:15-9:30 Question/Answer Session 9:30-10:00 The Genetics of Breast Cancer Barbara L. Weber, MD 10:00-10:15 Question/Answer Session 10:15-10:45 Genes and Susceptibility to Melanoma DuPont Guerry, IV, MD 10:45-11:00 Question/Answer Session 11:00-11:15 Break 11:15-11:45 Genetic Factors that Produce Familial Colorectal Cancer C. Richard Boland, MD 11:45-12:00 Question/Answer Session 12:00-12:30 Genetic Diagnosis of Medullary Thyroid Cancer in the Setting of MEN-2A, MEN-2B and FMTC Jeffrey A. Norton, MD 12:30-12:45 Question/Answer Session 12:45-1:45 Lunch Afternoon Session Presentations 1:45-2:15 Counseling and Psychosocial Issues in Genetic Testing for Cancer Risk Kathleen A. Calzone, RN, BSN 2:15-2:30 Video Presentation 2:30-3:00 Jill E. Stopfer, M.S., CGC 3:00-3:15 Question/Answer Session 3:15-3:45 Predictive Testing: The Insurer's Perspective Gary M. Owens, MD 3:45-4:00 Question/Answer Session 4:00-4:30 Is Knowledge Always a Good Thing? Ethics and Genetics Testing for Cancer Arthur L. Caplan, PhD 4:30-4:45 Question/Answer Session Services for the Disabled If special arrangements are required for an individual with a disability to attend this meeting, please contact Julia Stein no later than December 8, 1995, at 215-349-8387. Alec P. S. Schwartz (alecs@mail.med.upenn.edu) University of Pennsylvania Cancer Center Daytime: |Evening: 1223 Penn Tower (4283) |1803 Pine Street 3400 Spruce Street |Apartment 2-R Philadelphia, PA 19104 |Philadelphia, PA 19103-6601 | (215) 349-8053 |(215) 732-8705 (215) 349-8299 fax | ____________________________________________________________________________ Subj: Conference on DNA REPLICATION IN EUKARYOTES This message was originally submitted by dellaire@ATLAS.ODYSSEE.NET to the HMG-MOLGEN list at NIC.SURFNET.NL. 1st Announcement The Fourth McGill University Conference on Regulation of Eukaryotic DNA Replication St. Sauveur, Quebec, Canada October 1996. Organized by: Maria Zannis-Hadjopoulos and Gerald Price McGill Cancer Centre, Department of Oncology Faculty of Medicine and Faculty of Graduate Studies and Research McGill University http://www.mcgill.ca/mcgill/servers/Admin/UBO/dna.html The meeting will include plenary lecture sessions and poster sessions. TOPICS: * Eukaryotic Origins of DNA Replication * Nuclear and DNA Structure in DNA Replication * Modulation of Eukaryotic DNA Replication Preliminary Program The conference will be held at the Manoir Saint-Sauveur in the Laurentians. The first session will begin in the evening of October 17 and the final session will end in the early afternoon of October 20. Poster and oral presentations will take place on October 18 and 19. All participants are encouraged to present a poster on any of the topics that will be covered in the conference. Conference Location: The meeting will be held at the Laurentians' newest four-season conference resort hotel - a major luxury complex just about 45 minutes from Montreal, amid the dynamic beauty of the Laurentians. Saint-Sauveur-des-Monts, the Laurentians' most picturesque village, is the gateway village to the Laurentians. Transportation will be available from the airport to the conference site, and return. Registration materials and information regarding abstract submission will be sent in early 1996. *********Abstract deadline date: June 27, 1996.************ For More Information Please visit our Web Site http://www.mcgill.ca/mcgill/servers/Admin/UBO/dna.html >From this site you can obtain: * A Preliminary Program * Further Information on Conference Location * A Reply Card to Obtain Registration Package *************************************************************************** New Positions (many) The Department of Biology, San Francisco State University, is searching for a Developmental Biologist with research interests in gene expression associated with cell differentiation, pattern formation, or signal transduction, using an animal or plant system. The candidate is expected to establish an active research program, direct masters-level research students, seek extramural funding, and participate in the undergraduate and graduate curriculum. Teaching responsibilities will primarily include upper division and graduate courses in developmental biology. San Francisco State University is a comprehensive university whose faculty maintain strong commitment to teaching as well as to conducting and directing research. The position is for an Assistant or Associate Professor. A Ph.D. is required and postdoctoral experience is desirable. The Department consists of 35 faculty with diverse research programs in Cell and Molecular Biology and Microbiology, and Organismal and Population Biology. The successful applicant will have access to departmental core facilities that support research and teaching functions that house state-of-the art equipment including an automated sequencer and robotics. Questions regarding the position may be addressed to Michael A. Goldman, Chair, Developmental Biologist Search Committee, telephone number, 415-338-7671; e-mail, goldman@sfsu.edu, or at the address below. Applicants should forward a curriculum vitae, statements of teaching interests and research interests, and three letters of reference by 15 December, 1995, to Chair, Hiring Committee, Department of Biology, San Francisco State University, San Francisco, CA 94132. Women, ethnic minorities, and persons with disabilities are urged to apply. SFSU is an Equal Opportunity/Affirmative Action Employer. ------------------------------------------------------------ Michael A. Goldman, PhD. Professor Department of Biology San Francisco State University San Francisco, CA 94132-1722 Internet: goldman@sfsu.edu Tel: (415) 338-7671 Fax: (415) 338-2295 "Scientists have already cast much darkness upon the subject, and if they continue their investigations we shall soon know nothing at all about it." -- Mark Twain "An expert is someone who learns more and more about less and less until finally he knows everything about nothing." ------------------------------------------------------------- From: IN%"ED-MOLGEN@nic.SURFnet.nl" "Human Molecular Genetics Editors" 13-NOV-1995 18:31:03.84 To: IN%"ED-MOLGEN@nic.SURFnet.nl" "Multiple recipients of list ED-MOLGEN" CC: Subj: anno: open postdoc position in Biochemistry/Immunology This message was originally submitted by Goetz.Baumann@PKFMRG.PHARMA.SANDOZ.CH to the HUM-MOLGEN list at NIC.SURFNET.NL. We invite applications for a 'Postdoctoral Fellow' position in our 'Inflammation' department of 'Preclinical Research', Sandoz Pharma Ltd., Basel, Switzerland to work in a team on: 'Gene identification by oligonucleotide fingerprinting and profiling of gene expression in Rheumatoid Arthritis' Please send your detailed application as soon as possible to: Dr. Gotz Baumann Preclinical Research c/o Sandoz Pharma Ltd. CH-4002 Basel, Switzerland For questions and further information please contact by: E-mail: GOETZ.BAUMANN@SANDOZ.CH Tel. +41 61 324 5913 Fax. +41 61 324 2990 ________________________________________________________________________ Subj: ANNO: positions at Boehringer Mannheim GmbH This message was originally submitted by JOSEF_STURM_at_DEPZ-PERSONAL@BMG.CORAN GE.COM to the HUM-MOLGEN list at NIC.SURFNET.NL. R & D Scientist - Boehringer Mannheim GmbH Germany This is a permanent position located in Penzberg (Upper-Bavaria / near Munich). Your task would be to contribute to R&D -projects in the area of bone metabolism. You will be supported by your own little staff of technicians. You should be experienced in molecular developmental genetics and molecular cell biology. Ph.D. is necessary. Post Doctoral experience and / or first experience in leadership would be of advantage. Your German and English should be almost fluent. If you are interested in the position please send your complete application in paper form to: Boehringer Mannheim GmbH, Werk Penzberg, Personalreferat Penzberg 3, Nonnenwald 2, D-82377 Penzberg P.S.: Please use the code: ,hum-molgen position 01 BM" in your application form. R & D Neurobiologist - Boehringer Mannheim GmbH Germany Permanent position available at BM in Penzberg (Upper-Bavaria / near Munich). The cell biology department invites now applications for the position of a young highly motivated neurobiologist. Your task would be to establish primary cell-culture models for neurodegenerative diseases, to implement neuronal screening-assays and to develop viral expression-systems for neuronal cells. Furthermore you would have to produce and characterise monoclonal antibodies for different project groups. You will be supported by your own little staff of technicians. Ph.D. is necessary. Post Doctoral experience and / or first experience in leadership would be of advantage. Your German and English should be almost fluent. If you are interested in the position please send your complete application in paper form to: Boehringer Mannheim GmbH, Werk Penzberg, Personalreferat Penzberg 3, Nonnenwald 2, D-82377 Penzberg P.S.: Please use the code: ,hum-molgen position 02 BM" in your application form. ___________________________________________________________________________ Subj: Competitive Sabbatical Positions The Visiting Investigator Program National Center for Human Genome Research National Insitutes of Health (NIH) The Visiting Investigator Program is a competitive program that provides tenured or tenure-tract faculty level scientists from outside the NIH with the opportunity to spend a 3 - 12 month period at the National Center for Human Genome Research (NCHGR) laboratories and clinics at the NIH. Basic and clinical genetic researchers and social scientists can use their stay at the NCHGR to learn new technologies, develop research collaborations, or pursue sabbatical research projects. For application materials and information, contact: http://www.nchgr.nih.gov/dir/vip/ Betty Wolf-Ledbetter Director, Visiting Investigator Program National Center for Human Genome Research NIH, Building 9/1E106 9 Center Drive MSC 0950 Bethesda, MD 20892-0950 Tel: (301) 402-2012 Fax: (301) 402-2440 E-Mail: vip@nchgr.nih.gov __________________________________________________________________________ Subj: postdoc position This message was originally submitted by nerk057@RZBOX.UNI-WUERZBURG.DE to the HUM-MOLGEN list at NIC.SURFNET.NL. Department of Psychiatry Post-doctoral Position (Molecular Biologist/Geneticist) is available immediately to identify and study genes involved in psychiatric disorders. Our group presently focusing on gene expression is expanding its scope on novel gene mapping techniques. Applicants must have completed a Ph.D and should have at least two years of postdoctoral experience with several of the following experimental approaches presently used in the lab: advanced molecular biology and biochemistry techniques relevant to positional cloning, mammalian cell culture, mouse genetics (gene targeting & transgenics). The successful candidate will join a multidisciplinary environment with rich collaborative opportunities in basic and clinical research. Salary approx. DM 99.300 p.a. (BAT IIa). Please send cv, a description of research experience and the names and phone numbers of three references to: K.P. Lesch, M.D., Department of Psychiatry, University of Wuerzburg, Fchsleinstr. 15, D-97080 Wuerzburg, Germany _______________________________________________________________________ Subj: ANNO: Postdoc position - cytokine receptor activation This message was originally submitted by TGONDA@IMMUNO.IMVS.SA.GOV.AU to the HUM-MOLGEN list at NIC.SURFNET.NL. POST-DOCTORAL POSITION - CYTOKINE RECEPTOR ACTIVATION Hanson Centre for Cancer Research Institue of Medical and Veterinary Science Adelaide, South Australia PROJECT: Analysis of activating mutations in the beta subunit of the granulocyte-macrophage colony stimulating (GM-CSF) factor receptor. BACKGROUND: The GM-CSF receptor comprises two subunits, (alpha and beta) which are both members of the cytokine receptor superfamily. We have recently identified a number of mutations in the beta subunit (ref. EMBO J 14:4276-4287 (1995)) which result in its constitutive activity. These mutations and allow proliferation of normally factor-dependent cells in the absence of exogenous GM-CSF and are oncogenic in such cell lines. Current studies in the laboratory aim to: - elucidate how these mutations activate the beta subunit; - examine the intracellular signalling pathways triggered by the activated receptor in different cell types; - identify other components of the receptor complex that are required for receptor signalling. The findings from these studies will be relevant to understanding normal GM-CSF receptor function - and by analogy, that of other cytokine receptors - and will allow investigation of the potential role of the beta subunit in leukaemia. FURTHER INFORMATION: Contact Dr Tom Gonda on phone: +61-8-222-3305; FAX +61-8-232-4092; E-mail: tgonda@immuno.imvs.sa.gov.au ____________________________________________ ____________________________________________ Tom Gonda Hanson Centre for Cancer Research Institute of Medical and Veterinary Science Frome Road, Adelaide, SA 5000 Australia Ph. +61-8-222-3305 FAX +61-8-232-4092